Kaitlyn Arsenault, Chief Financial Officer at Skye Bioscience, Inc. (SKYE), sold 86,052 shares at $4.99 ($429K) on 2024-11-18, disclosed to the SEC on 2025-02-28.
Open-market sale of $429k SKYE by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 43,026 | $215K | 50.0% |
| 2 | $4.99 | 43,026 | $215K | 50.0% |
| Total | $4.99 avg | 86,052 | $429K | 100% |